India  

FDA says a coronavirus vaccine would have to be at least 50% effective to be approved

USATODAY.com Tuesday, 30 June 2020 ()
A coronavirus vaccine would ideally be proven to be at least 50% effective for the Food and Drug Administration to approve it.
0
shares
ShareTweetSavePostSend
 
Video credit: Wochit - Published
News video: Coronavirus Vaccine: How Close Are We?

Coronavirus Vaccine: How Close Are We? 00:37

Researchers around the world are developing more than 145 vaccines against the coronavirus. 19 vaccines are in human trials but vaccines typically require years of research and testing. Scientists are racing to produce a safe and effective vaccine by next year, says Business Insider. The first...

You Might Like


💡 newsR Knowledge: Other News Mentions

Food and Drug Administration Food and Drug Administration Agency of the United States Department of Health and Human Services

Too soon to say if RNC will be safe -U.S. official [Video]

Too soon to say if RNC will be safe -U.S. official

Stephen Hahn, the Food and Drug Administration commissioner, said on Sunday it was "too early to tell" if it would be safe for people to attend August's Republican National Convention in Jacksonville, Florida. This report produced by Chris Dignam.

Credit: Reuters Studio    Duration: 01:43Published
FDA Commissioner Won't Confirm Or Deny Trump's Unfounded COVID-19 Claim [Video]

FDA Commissioner Won't Confirm Or Deny Trump's Unfounded COVID-19 Claim

The commissioner of the US Food and Drug Administration on Sunday didn't defend a claim recently made by President Donald Trump. But according to CNN, he didn't support it, either. Dr. Stephen Hahn is a member of the White House coronavirus task force. At a White House Independence Day event on Saturday, Trump made an unfounded claim that 99% of coronavirus cases are 'totally harmless.' In a CNN interview with Dana Bash on Sunday, Dr.

Credit: Wochit News    Duration: 00:45Published
Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment [Video]

Gilead to Charge $3,120 Per Patient for Typical Covid-19 Treatment

Gilead is the pharmaceutical company behind a drug that’s been approved for COVID emergencies. The FDA officially announced the medicine could be used in treating COVID-19 patients. Gilead has now announced the drug will cost $3,120 per typical treatment course for insured individuals. Research has indicated the drug could cut the recovery time for hospitalized COVID-19 patients. It could shorten satsy by several days, reports Gizmodo.

Credit: Wochit News    Duration: 00:35Published
Former FDA head says 'exponential' rise in COVID-19 possible [Video]

Former FDA head says 'exponential' rise in COVID-19 possible

Former Food and Drug Administration Commissioner Scott Gottlieb on Sunday warned that some U.S. states, including Texas, Florida and Arizona, could start to see an 'exponential' rise in COVID-19 cases this coming week. This report produced by Yahaira Jacquez.

Credit: Reuters - Politics    Duration: 01:40Published

Related videos from verified sources

Face mask of gold: Pune man splurges Rs 2.8 lakh on unique mask amid Covid [Video]

Face mask of gold: Pune man splurges Rs 2.8 lakh on unique mask amid Covid

A Pune resident has shot to limelight with a unique face mask. Shankar Kurade of Pimpri-Chinchwad splurged Rs 2.89 lakh on a mask made of gold. He reportedly said that the mask has minute holes for air..

Credit: HT Digital Content     Duration: 01:08Published
S&P, Nasdaq rally on vaccination hopes [Video]

S&P, Nasdaq rally on vaccination hopes

The S&P 500 and Nasdaq closed higher Wednesday to kick off the third quarter as increasing optimism for a safe and effective COVID-19 vaccine eased concerns that another round of business lockdowns was..

Credit: Reuters Studio     Duration: 01:24Published
Which DIY masks are most effective? [Video]

Which DIY masks are most effective?

If you are looking to make your own face mask, quilting it may be the way to go. Researchers at Florida Atlantic University measured how effective different DIY masks are.

Credit: KTNV Channel 13 Las Vegas     Duration: 00:24Published

Tweets about this

Zonoo7

Zonoo Demand for dexamethasone rises after study finds COVID-19 benefits, FDA data shows https://t.co/yeQuomVxdn 3 days ago

FokGin

HAITI FÒK GIN SANTÉ Demand for dexamethasone rises after study finds COVID-19 benefits, FDA data shows https://t.co/gnqXXGnYDA 3 days ago

Michael_Dvdov

Michael Davidov RT @theresaboyle: Demand for dexamethasone rises after study finds COVID-19 benefits, FDA data shows - USA TODAY https://t.co/xPa59IY9bw 3 days ago

theresaboyle

Theresa Boyle Demand for dexamethasone rises after study finds COVID-19 benefits, FDA data shows - USA TODAY https://t.co/xPa59IY9bw 3 days ago

Indedotcom

IndeOnline.com An inexpensive steroid that was in shortage before the COVID-19 outbreak has become more scarce as demand rises. De… https://t.co/uubOEcILoA 4 days ago

CantonRepdotcom

CantonRep.com After a study showed dexamethasone reduced the risk of death in coronavirus patients, the inexpensive steroid is in… https://t.co/k9oSVlkQTJ 4 days ago

Indedotcom

IndeOnline.com A study from the University of Oxford published June 16 shows dexamethasone reduced the risk of death by up to one-… https://t.co/PoujuzPKnq 4 days ago

CantonRepdotcom

CantonRep.com A study from the University of Oxford published June 16 shows dexamethasone reduced the risk of death by up to one-… https://t.co/2g13RDXtB7 4 days ago